Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(50.0%)
N/A
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 3(2)
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05594862Not ApplicableActive Not Recruiting

Treatment of Crohn's Complex Perianal Fistulas With Tissue Transplantation by Local Injection of Micro-fragmented Autologous Adipose Tissue.

Role: lead

NCT06121882Phase 3Active Not Recruiting

Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis

Role: lead

NCT05660772Phase 3Completed

Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis

Role: lead

NCT03117608Phase 4Unknown

A Single Intra-articular Injection of aMAT vs PRP in Patients With OA of the Knee

Role: lead

All 4 trials loaded